Prempro jury levies damages against Wyeth
For the third time in a row, the jury in a drug liability case has sided against pharma. Having already concluded that Wyeth’s Prempro hormone replacement therapy was linked to plaintiff Cindy Barton’s breast cancer, the 8-member panel awarded $3.75 million in compensatory damages. The jury had also found that Wyeth hid evidence of the potential cancer risk, and for that it levied punitive damages.
